Neurolutions
Company · Santa Cruz, California, USA
Makes IpsiHand, the first FDA-authorized BCI system for stroke rehabilitation.
IpsiHand uses EEG to detect a stroke survivor’s intention to move and drives a hand exoskeleton in response, strengthening the brain’s recovery pathways. It received FDA De Novo authorization in 2021.
In the news
Clinical trialsNon-invasive
Randomized trial: IpsiHand BCI helps stroke survivors regain arm function years after stroke
In 62 chronic stroke survivors, 55.5% of those using the EEG-based BCI had clinically meaningful recovery versus 9.6% of controls.